Eris Lifesciences buys vildagliptin brand Zomelis from Novartis for $13 million Eris added that it will start selling the product in the Indian market from December 10 onwards.
Feedback
ERIS 
Reputation: 2,149 • Dec 4, 2019 1:05 PM
Vote
Comment
Share